Catalyst Wire Dossier Catalyst Wire Dossier

MG1 Maraba

MG1 Maraba virus vector
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MG1 Maraba, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours [Phase 1, Phase 2]

See pricing